MeiraGTx Holdings (MGTX) Other financing activities (2018 - 2025)
MeiraGTx Holdings (MGTX) reported Other financing activities of $19.3 million for Q4 2025, down 4.92% on a YoY basis from $20.3 million in Q4 2024, and up 237.43% quarter-over-quarter from $5.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Other financing activities (2018 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Other financing activities for 8 years, with the latest figure at $19.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities fell 4.92% year-over-year to $19.3 million; the trailing twelve-month figure through Dec 2025 stood at $32.9 million (down 11.26% YoY), and the FY2025 full-year result was $19.4 million, down 15.23% from the prior year.
- Other financing activities for Q4 2025 stood at $19.3 million, up from $5.7 million in the prior quarter.
- The five-year high for Other financing activities was $22.5 million in Q4 2021, with the low at $206000.0 in Q4 2022.
- Historically, Other financing activities has averaged $7.5 million across 5 years, with a median of $5.7 million in 2025.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 99.08% — and 2023, when it soared 1016.02%.
- MeiraGTx Holdings' Other financing activities stood at $22.5 million in 2021, then plunged by 99.08% to $206000.0 in 2022, then soared by 1016.02% to $2.3 million in 2023, then surged by 784.99% to $20.3 million in 2024, then dropped by 4.92% to $19.3 million in 2025.
- The last three Other financing activities figures came in at $19.3 million (Q4 2025), $5.7 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.35 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 20.35 Mn |
| Dec 31, 2024 | 20.35 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.77 Mn |